EU-AIMS was kicked off with a Kick-off Meeting which took place at Zurich from 3 - 4 April 2012 as one of the largest ever research academic-industry collaboration projects to find new methods for the development of drugs for autism spectrum disorder (ASD).
The photo shows from left to right: Prof. Dr. Declan Murphy (Managing Director of EU-AIMS, Head of Department of Forensic and Neurodevelopmental Sciences (IOP), King's College London), Prof. Dr. Anirvan Ghosh (Head of Discovery for Central Nervous System (CNS) at F. Hoffmann – La Roche), Prof. Dr. Michel Goldman (Executive Director of IMI - Innovative Medicine Initiative), and Dr. Will Spooren (Coordinator of EU-AIMS, Head Neurodevelopmental and Behavioral Neuroscience at F. Hoffmann – La Roche).
This meeting was restricted only for EU-AIMS members.
Read the EU-AIMS Kick-Off press release!
EU-AIMS Kick-Off press release (270 KB)